Sep 13, 2022 / 02:00PM GMT
Mark Douglas Purcell - Morgan Stanley, Research Division - Equity Analyst
Okay. Good morning, everyone. I think we'll get started. My name is Mark Purcell. I'm one of the European Pharmaceuticals here at Morgan Stanley. I'm joined by Thibault Boutherin my colleague from London as well. It gives me great pleasure seen Sanofi today.
We have 2 people. We have Frank Nestle, who is the Global Head of Research and the Chief Scientific Officer; and we have Frank DeRosa, who is the Chief Technology Officer and Global Head of Research and biomarkers for Sanofi vaccines.
Before we get started, I just have to read out a statement for important disclosures, please see the Morgan Stanley Research Disclosures website at www.morganstanley.com/researchdisclosures. (Operator Instructions). So gentlemen, thanks for joining us. It's great to see you in person again.
Frank Nestle - Sanofi - Global Head of Immunology & Inflammation Research and Chief scientific Officer - North America<
Sanofi SA at Morgan Stanley Global Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers